Jones Trading Maintains Buy on Janux Therapeutics, Lowers Price Target to $28

Benzinga Newsdesk www.benzinga.com Negative 71.6%

Neg 71.6% Neu 0% Pos 0%

Jones Trading analyst Boris Peaker maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and lowers the price target from $50 to $28.